A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Proof of concept; Therapeutic Use
- Acronyms PENNANT
- Sponsors Mallinckrodt LLC
- 14 Jun 2017 According to a Mallinckrodt media release, first patient has been enrolled in this trial.
- 14 Jun 2017 Status changed from not yet recruiting to recruiting, according to a Mallinckrodt media release.
- 01 Mar 2017 Status changed from planning to not yet recruiting.